Varicella zoster virus encephalitis: a potentially serious complication during treatment with vedolizumab
Miriam Celada-Sendino1, Lorena Carballo-Folgoso1, Ruth de Francisco2
1Aparato Digestivo, Hospital Universitario Central de Asturias, España.
Abstract:
Vedolizumab is a monoclonal antibody that has demonstrated efficacy and a good safety profile in patients with inflammatory bowel disease. Varicella zoster virus encephalitis is a potentially serious complication not previously described with its use, highlighting the importance of vaccination, as well as early diagnosis and treatment of infections in this type of patients.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
09:35Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Related Concept Videos
Allergic Drug Reactions
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Antiepileptic Drugs: Glutamate Antagonists
Pneumonia III: Complications and Assessment
